ECMO Market Is Predicted To Grow Swiftly Due To The Growing Number Of Respiratory Failure Cases & Conditions Till 2024: Grand View Research, Inc.

The extracorporeal membrane oxygenation market is expected to reach USD 346.1 million by 2024, according to a new report by Grand View Research, Inc. The growing number of respiratory failure cases and conditions, such as cardiopulmonary disease and Chronic Obstructive Pulmonary Disease (COPD) is anticipated to boost the market growth. For instance, according to the U.SNational Center for Health statistics, in the year 2014, there were about 149,205 deaths due to chronic lower respiratory disorders in the U.S. 

Moreover, the increased adoption of ECMO machines in hospitals as a consequence ofthe medical community taking cognizance of the advantages related to the use of ECMO machines is anticipated to facilitate the emergence of this market during the forecast period. 

Apart from the high applicability of these appliances in hospitals, technological advancements have played a pivotal role in further accelerating the usage of these devices. For instance, Medtronic’s Century heart lung machine, which consists of an arterial pump, data management system and cardioplegia delivery system, is employed to provide cardiopulmonary functional support to patients. 

North America extracorporeal membrane oxygenation market share, by application, 2013-2024 (USD Million)




Further key findings from the report suggest:

  • The veno-venous segment held a lucrative sharein 2015 among the modality types owing to its efficiency and reliability in furnishing gas exchange support.
  • The respiratory application segment held a remunerative share in 2015; this is attributed to the increasing number of patients suffering from respiratory conditions. Moreover, the technological advancement in the ECMO machines has further increased its adoption rate in hospitals for its use in respiratory failure conditions.
  • North America dominated the overall market with a revenue share of over 40.0% in 2015 owing to the presence of a well-developed infrastructure and a suitable reimbursement framework as well as the rise in number of supportive government funds.
  • However, Asia Pacific is anticipated to be the fastest growing region with a CAGR of about 5.0% over the forecast period. Notable economic developments and the advancing healthcare system developed with the aid of supportive government initiatives are anticipated to assist the growth.
  • Moreover, the rising incidences of respiratory failure and cardiopulmonary diseases are identified as major impact rendering factors for the growth of this market. According to the World Health Organization, about 3 million deaths were reported globally due to COPD in the year 2012, which accounts for 6% of the total mortality.
  • Some leading players in this vertical include Maquet Holding B. V. & Co.KG, Microport Scientific Corporation, Medos Medizintechnik AG, Sorin Group, Medtronic Plc, Terumo Cardiovascular Systems Corporation, and Nipro Medical Corporation.
  • These key players opt for technologically enhanced products and undertake collaborations with other companies to implement new product development strategy goals to sustain a competitive advantage in the industry. For instance, Medtronic Plc collaborated with Salyer Biomedical, LLC for the development of their product, Century heart lung machine. 
About Grand View Research, Inc:

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.


For more information: http://www.grandviewresearch.com

Comments

Popular posts from this blog

The global vein illuminator market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future. The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly. On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America. Browse full research report on global Vein Illuminator Market: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market Further key findings from the study suggest: • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region. • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment. • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions. • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26th patent, which was issued by the United States Patent and Trademark office for their vein visualization system. Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application: Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 - 2024) • Transillumination • Infrared technology • Others Vein Illuminator Application Outlook (Revenue, USD Million, 2013 - 2024) • Intravenous access • Blood draw • Others Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 - 2024) • Hospitals • Blood donation camps • Academic institutions • Others Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 - 2024) • North America • Europe • Asia Pacific • Latin America • MEA Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-vein-illuminator-market About Grand View Research Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc For more information: www.grandviewresearch.com

Hyaluronic Acid Market Is Likely To Be Influenced By The Increase In Obesity Till 2024: Grand View Research, Inc.

Protein Purification & Isolation Market Is Predicted To Grow Swiftly Due To Increased Research In The Fields Of Biotechnology & Pharmaceuticals Till 2025: Grand View Research, Inc.